title: Functional studies of tyrosine hydroxylase missense variants reveal distinct patterns of molecular defects in Dopa-responsive dystonia.
abstract: Congenital tyrosine hydroxylase deficiency (THD) is found in autosomal-recessive Dopa-responsive dystonia and related neurological syndromes. The clinical manifestations of THD are variable, ranging from early-onset lethal disease to mild Parkinson disease-like symptoms appearing in adolescence. Until 2014, approximately 70 THD patients with a total of 40 different disease-related missense mutations, five nonsense mutations, and three mutations in the promoter region of the tyrosine hydroxylase (TH) gene have been reported. We collected clinical and biochemical data in the literature for all variants, and also generated mutant forms of TH variants previously not studied (N = 23). We compared the in vitro solubility, thermal stability, and kinetic properties of the TH variants to determine the cause(s) of their impaired enzyme activity, and found great heterogeneity in all these properties among the mutated forms. Some TH variants had specific kinetic anomalies and phenylalanine hydroxylase, and Dopa oxidase activities were measured for variants that showed signs of altered substrate binding. p.Arg233His, p.Gly247Ser, and p.Phe375Leu had shifted substrate specificity from tyrosine to phenylalanine and Dopa, whereas p.Cys359Phe had an impaired activity toward these substrates. The new data about pathogenic mechanisms presented are expected to contribute to develop individualized therapy for THD patients.
authors.affiliation: Department of Biomedicine, University of Bergen, Bergen, Norway; K. G. Jebsen Centre for Research on Neuropsychiatric Disorders, University of Bergen, Bergen, Norway.
authors.forename: Agnete
authors.initials: A
authors.lastname: Fossbakk
authors.forename: Rune
authors.initials: R
authors.lastname: Kleppe
authors.forename: Per M
authors.initials: PM
authors.lastname: Knappskog
authors.forename: Aurora
authors.initials: A
authors.lastname: Martinez
authors.forename: Jan
authors.initials: J
authors.lastname: Haavik
mesh_terms: D018450:Disease Progression; D020821:Dystonic Disorders / Q000175:diagnosis / Q000235:genetics*; D004789:Enzyme Activation; D004795:Enzyme Stability; D015870:Gene Expression; D006801:Humans; D008958:Models, Molecular; D020125:Mutation, Missense; D011487:Protein Conformation; D011994:Recombinant Proteins / Q000737:chemistry / Q000235:genetics / Q000302:isolation & purification / Q000378:metabolism; D012995:Solubility; D013379:Substrate Specificity; D014446:Tyrosine 3-Monooxygenase / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism*
chemical_list: D011994:Recombinant Proteins; D014446:Tyrosine 3-Monooxygenase
keywords: Dopa responsive dystonia; THD; tyrosine hydroxylase deficiency
references.citation: Mov Disord. 2013 Jul;28(8):1058-63
references.pmid: 23389938
references.citation: Nat Struct Biol. 1997 Jul;4(7):578-85
references.pmid: 9228951
references.citation: Brain. 2009 Jul;132(Pt 7):1753-63
references.pmid: 19491146
references.citation: Mol Genet Metab. 2010 Apr;99(4):431-3
references.pmid: 20056467
references.citation: J Parkinsons Dis. 2011;1(1):119-22
references.pmid: 23939262
references.citation: Nature. 1987 Apr 16-22;326(6114):707-11
references.pmid: 2882428
references.citation: Hum Mutat. 2010 Oct;31(10):E1767-71
references.pmid: 20809526
references.citation: Hum Mol Genet. 1995 Jul;4(7):1209-12
references.pmid: 8528210
references.citation: J Bioenerg Biomembr. 1995 Dec;27(6):583-96
references.pmid: 8746845
references.citation: Biochemistry. 2013 Feb 26;52(8):1446-55
references.pmid: 23368961
references.citation: J Child Neurol. 2012 Apr;27(4):523-5
references.pmid: 21940685
references.citation: FEBS Lett. 2004 May 7;565(1-3):155-9
references.pmid: 15135070
references.citation: J Neurochem. 1997 Jan;68(1):328-32
references.pmid: 8978742
references.citation: Hum Genet. 1995 Jun;95(6):716
references.pmid: 7789962
references.citation: Neuroscience. 2008 Aug 13;155(2):485-91
references.pmid: 18593594
references.citation: Anal Biochem. 2005 Aug 1;343(1):100-5
references.pmid: 15963939
references.citation: Mol Genet Metab. 2011;104 Suppl:S2-9
references.pmid: 21937252
references.citation: Nature. 1995 Apr 13;374(6523):640-3
references.pmid: 7715703
references.citation: Brain. 2010 Jun;133(Pt 6):1810-22
references.pmid: 20430833
references.citation: IUBMB Life. 2013 Apr;65(4):341-9
references.pmid: 23457044
references.citation: Protein Sci. 1995 Mar;4(3):538-41
references.pmid: 7795535
references.citation: Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W382-8
references.pmid: 15980494
references.citation: Amino Acids. 2002;23(1-3):57-63
references.pmid: 12373519
references.citation: J Inherit Metab Dis. 2010 Dec;33(6):649-58
references.pmid: 20824346
references.citation: J Mol Biol. 2002 Jul 26;320(5):1095-108
references.pmid: 12126628
references.citation: J Neurochem. 2010 Aug;114(3):853-63
references.pmid: 20492352
references.citation: Protein Expr Purif. 2004 Feb;33(2):185-94
references.pmid: 14711505
references.citation: PLoS One. 2013 Jun 06;8(6):e65215
references.pmid: 23762320
references.citation: Eur J Biochem. 1991 Jul 15;199(2):371-8
references.pmid: 1676967
references.citation: Am J Hum Genet. 2007 Nov;81(5):1006-24
references.pmid: 17924342
references.citation: Annu Rev Biochem. 1999;68:355-81
references.pmid: 10872454
references.citation: J Biol Chem. 1999 Nov 19;274(47):33251-8
references.pmid: 10559199
references.citation: Comp Biochem Physiol C Comp Pharmacol Toxicol. 1991;98(1):203-10
references.pmid: 1673911
references.citation: Hum Mutat. 2009 May;30(5):787-94
references.pmid: 19319927
references.citation: Neurology. 2012 Jul 31;79(5):435-41
references.pmid: 22815559
references.citation: Hum Mol Genet. 1996 Jul;5(7):1023-8
references.pmid: 8817341
references.citation: J Biochem. 1994 Aug;116(2):393-8
references.pmid: 7822259
references.citation: Proteins. 2005 Jan 1;58(1):14-21
references.pmid: 15468323
references.citation: J Neural Transm (Vienna). 2013 Jan;120(1):49-54
references.pmid: 22644539
references.citation: Eur J Biochem. 1999 Jun;262(3):840-9
references.pmid: 10411647
references.citation: Am J Hum Genet. 2008 Jul;83(1):5-17
references.pmid: 18538294
references.citation: Hum Mutat. 2007 Sep;28(9):831-45
references.pmid: 17443661
references.citation: J Am Chem Soc. 2003 May 14;125(19):5677-86
references.pmid: 12733906
references.citation: Clin Chem. 1999 Dec;45(12):2073-8
references.pmid: 10585338
references.citation: Bioinformatics. 2009 Nov 1;25(21):2744-50
references.pmid: 19734154
references.citation: Pediatr Neurol. 2012 Feb;46(2):77-82
references.pmid: 22264700
references.citation: J Med Chem. 2004 Nov 18;47(24):5962-71
references.pmid: 15537351
references.citation: Biochim Biophys Acta. 2009 Dec;1793(12):1860-7
references.pmid: 19833152
references.citation: Amino Acids. 2008 Apr;34(3):455-64
references.pmid: 17520326
references.citation: J Chromatogr. 1980 Oct 24;198(4):511-5
references.pmid: 6108329
references.citation: Hum Mutat. 2004 Nov;24(5):388-99
references.pmid: 15459954
references.citation: J Neurochem. 1997 Oct;69(4):1720-8
references.pmid: 9326301
references.citation: J Neurochem. 2008 Jul;106(2):672-81
references.pmid: 18419768
references.citation: Mov Disord. 2009 Apr 30;24(6):943-5
references.pmid: 19224593
references.citation: Mol Neurobiol. 1998 Jun;16(3):285-309
references.pmid: 9626667